PeptideStack
5.2kquestions
20kanswers
220users

Does vomiting at week twelve of oral semaglutide usually resolve without a dose change?

Asked 15 Apr 2025Modified 13 months agoViewed 17k times
31

The particulars: vomiting · twelve · oral semaglutide.

I would like to understand the steps well enough to explain them to someone else.

I have access to a refrigerator with a logger and a freezer without one, which may be relevant.

Which parts of this are load-bearing and which parts are habit?

vomiting
vomiting

Emesis as a reported adverse event: trial incidence, its relationship to dose escalation rate, dehydration risk, and when it stops being a…

57 questions
titration
titration

Stepwise dose increases over weeks, why the label schedules exist at all, and what tolerability-driven deviation from a schedule looks like in…

456 questions
oral-glp1
oral-glp1

Oral routes for GLP-1 receptor agonism: peptide formulations rescued by absorption enhancers such as SNAC, and true small molecules that need no…

219 questions
shareeditfollowflag
DB
askedDr_Ingrid_Baumgartner73k5815 Apr 2025
Same experience, and it settled in about ten days at the same step. – Dr_Rosalind_Achebe 38 days ago
add a comment

5 Answers

Sorted by votes
16

Week 12 is day 84: on a four-week ladder that is week 4 of dose step 3, and — at the seven-day half-life this class runs on — 12 half-lives in. Steady state is about five half-lives, so day 35 is where the concentration stops climbing on its own. Day 84 is 7 weeks past it, which means the level is no longer the variable. That distinction is most of the question: at week 4 of a step, an effect that is still accumulating is indistinguishable from one that is not resolving unless you know which side of day 35 you are on. Vomiting is the rarer and more informative of the pair. It follows the same escalation weeks as nausea, so one arriving well away from a step is pointing at something other than the ladder. Dose decisions are made under supervision, and nothing here is medical advice.

Answer first: vomiting is less common than nausea, is more strongly dose-related, and matters chiefly because of what it does to fluid and electrolyte balance.

Warning signs that convert this from a nuisance to a clinical problem: inability to keep fluids down for more than a few hours, reduced urine output, dizziness on standing, confusion, or severe abdominal pain.

Dental enamel erosion from repeated vomiting is a real if unglamorous consequence; rinsing with water rather than brushing immediately is the standard advice.

Small frequent sips of an oral rehydration solution, not large volumes of water.

edited 13 May 2025 by Dr_Nadia_Farsi — clarified the distinction between purity and content

shareimprove this answerflag
DF
answeredDr_Nadia_Farsi104k2472 May 2025
2The distinction between escalation-related and steady-state is the useful part. – plate_count_9k 4 months ago
add a comment
Sponsored

PeptideMeter - Independent Peptide Analytics

Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.

Browse results
12

The short version: usually escalation-related, usually self-limiting, and dangerous mainly through dehydration.

Oral rehydration solutions work by glucose-coupled sodium co-transport, which continues to function when secretion is deranged. That is why the glucose-to-sodium ratio matters and a high-sugar sports drink is not equivalent.

Repeated vomiting is the mechanism behind most reported acute kidney injury in this class. The renal event is a volume event, not a direct toxicity.

The caveat is that persistent vomiting is a clinical situation and this is not the place to manage one.

The renal risk here is volume, not toxicity. That is the mechanism to watch.

shareimprove this answerflag
DO
answeredDr_Lena_Ostrowska38k2721 Apr 2025
7Does the tolerance develop at the same rate for the daily agents? – Dr_Idris_Coulibaly 4 months ago
8The red-flag list should be higher up the answer, not at the bottom. – Dr_Priya_Raghunathan 6 months ago
add a comment
10

Start with frequency and duration, because an isolated episode after an escalation and repeated episodes over days are different problems.

Trial incidence for vomiting runs at roughly a third to a half of the nausea rate depending on agent and dose, and it is more concentrated in the escalation phase than nausea is.

An episode of vomiting several days after a dose, with no escalation and no other explanation, is not the typical pattern and deserves attention rather than tolerance.

Oral rehydration solution composition is standardised by the World Health Organization and rests on glucose-coupled sodium transport.

Research-use material is not approved for human use, and an unverified dose is an unquantifiable variable in any of this.

If fluids will not stay down for several hours, that is the threshold. Get help.

shareimprove this answerflag
DL
answeredDr_Otto_Lindqvist72k5825 May 2025
9

More usefully, rehydration with an oral rehydration solution is more effective than water and is not the same as a sports drink.

A practical home formulation is about six level teaspoons of sugar and half a level teaspoon of salt in one litre of water, taken in small frequent sips rather than in volumes that provoke another episode.

Do not escalate the dose while this is happening.

shareimprove this answerflag
DF
answeredDr_Nadia_Farsi104k24713 May 2025
4

The honest answer is that a day of it is unpleasant and that several days of it needs help.

Fluid lost in vomit carries sodium at roughly 60 millimoles per litre and potassium at rather less, so replacing it with plain water alone dilutes plasma sodium rather than restoring balance.

Electrolyte composition of gastric and intestinal secretions is published and is the basis for replacement calculations.

Rinse rather than brush after an episode. Enamel is not replaceable.

shareimprove this answerflag
RS
answeredruaidhri_o_shea25k2716 Jun 2025
Any published figure for how long the constipation persists, given it does not attenuate? – tenth_of_a_unit 7 months ago
add a comment

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.